These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Molecular characterisation of macrolide resistance mechanisms of Streptococcus pneumoniae and Streptococcus pyogenes isolated in Germany, 2002-2003. Reinert RR; Franken C; van der Linden M; Lütticken R; Cil M; Al-Lahham A Int J Antimicrob Agents; 2004 Jul; 24(1):43-7. PubMed ID: 15225860 [TBL] [Abstract][Full Text] [Related]
8. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens. Noviello S; Ianniello F; Leone S; Esposito S J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672 [TBL] [Abstract][Full Text] [Related]
9. [The extent of resistance on clinically important pathogens in the Federal Republic]. Pulverer G Adv Clin Pharmacol; 1974; 8():21-32. PubMed ID: 4157112 [No Abstract] [Full Text] [Related]
10. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus. Nord CE; Lindmark A; Persson I J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369 [No Abstract] [Full Text] [Related]
12. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections]. Li JT; Li Y; Wang J; Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911 [TBL] [Abstract][Full Text] [Related]
13. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Boos M; Mayer S; Fischer A; Köhrer K; Scheuring S; Heisig P; Verhoef J; Fluit AC; Schmitz FJ Antimicrob Agents Chemother; 2001 Mar; 45(3):938-42. PubMed ID: 11181385 [TBL] [Abstract][Full Text] [Related]
14. The binding of penicillin in relation to its cytotoxic action. II. The reactivity with penicillin of resistant variants of streptococci, pneumococci, and staphylococci. EAGLE H J Exp Med; 1954 Jul; 100(1):103-15. PubMed ID: 13163342 [TBL] [Abstract][Full Text] [Related]
15. Haemophilus influenzae, Pneumococci, group A streptococci and Staphylococcus aureus: sensitivity of outpatient strains to commonly prescribed antibiotics. Forsgren A; Walder M Scand J Infect Dis; 1982; 14(1):39-43. PubMed ID: 7041247 [TBL] [Abstract][Full Text] [Related]
16. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens]. Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections. Mazur E; Ligieza J; Niedźwiadek J; Polak G; Kozioł-Montewka M; Hencner Z Ann Univ Mariae Curie Sklodowska Med; 1999; 54():407-10. PubMed ID: 11205800 [No Abstract] [Full Text] [Related]
18. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study). Jacobs E; Dalhoff A; Korfmann G Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763 [TBL] [Abstract][Full Text] [Related]
19. [Sensitivity of Streptococcus pneumoniae to antimicrobial drugs]. Mihajlović-Ukropina M; Milutinović M Med Pregl; 1998; 51(3-4):169-73. PubMed ID: 9611963 [TBL] [Abstract][Full Text] [Related]
20. In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci. Roveta S; Marchese A; Debbia EA; Bandettini R Int J Antimicrob Agents; 2008 Feb; 31(2):185-7. PubMed ID: 18082375 [No Abstract] [Full Text] [Related] [Next] [New Search]